Establishment of an animal model of immune-related adverse events induced by immune checkpoint inhibitors.
Yuan MengYingge LvMeng ShenWenwen YuYumeng LiuTing LiuGen LiuShiya MaZhenzhen HuiXiubao RenLiang LiuPublished in: Cancer medicine (2024)
The irAE-related animal model was successfully established in BALB/c mice using a combination of PD-1 and CTLA-4 inhibitors through multiple administrations with clinical translational value and practical. This model offers valuable insights into irAE mechanisms for further investigation.